Skip to main content

ADVERTISEMENT

Mary Beth Nierengarten

11/20/2020
A newly launched program to integrate social determinants of health into clinical care is putting into practice what many health policymakers, plans, and providers are increasingly trying to get their heads around—how to more fully and...
A newly launched program to integrate social determinants of health into clinical care is putting into practice what many health policymakers, plans, and providers are increasingly trying to get their heads around—how to more fully and...
A newly launched program to...
11/20/2020
First Report Managed Care
05/17/2016
On Monday, April 25, 2016, the Centers for Medicare & Medicaid Services (CMS) released its final rule updating managed care in Medicaid and the Children’s Health Insurance Program (CHIP). Overall, nearly 900 individuals and organizations...
On Monday, April 25, 2016, the Centers for Medicare & Medicaid Services (CMS) released its final rule updating managed care in Medicaid and the Children’s Health Insurance Program (CHIP). Overall, nearly 900 individuals and organizations...
On Monday, April 25, 2016, the...
05/17/2016
Population Health
02/19/2014
San Diego—In patients with early rheumatoid arthritis (RA), treatment with triple disease-modifying antirheumatic drug (DMARD) therapy was found superior to methotrexate monotherapy, even after 12 months of therapy. The superior benefit of...
San Diego—In patients with early rheumatoid arthritis (RA), treatment with triple disease-modifying antirheumatic drug (DMARD) therapy was found superior to methotrexate monotherapy, even after 12 months of therapy. The superior benefit of...
San Diego—In patients with early...
02/19/2014
First Report Managed Care
05/24/2012
San Francisco—Efforts to reduce fraud, waste, and abuse (FWA) in the US healthcare system are getting a boost from the federal government under the Patient Protection and Affordable Care Act that is allotting $350 million over the next 10...
San Francisco—Efforts to reduce fraud, waste, and abuse (FWA) in the US healthcare system are getting a boost from the federal government under the Patient Protection and Affordable Care Act that is allotting $350 million over the next 10...
San Francisco—Efforts to reduce...
05/24/2012
First Report Managed Care
Conference Insider
02/22/2012
Chicago—The risk of serious infection was not significantly increased in patients with autoimmune diseases initiating treatment with tumor necrosis factor (TNF) antagonists compared with those treated with nonbiologic disease regimens, even...
Chicago—The risk of serious infection was not significantly increased in patients with autoimmune diseases initiating treatment with tumor necrosis factor (TNF) antagonists compared with those treated with nonbiologic disease regimens, even...
Chicago—The risk of serious...
02/22/2012
First Report Managed Care
Feature Story
09/16/2021
With the ever-increasing costs of drugs, experts are looking more closely at methods to contain costs for payers and improve affordability and access for patients; however, some stakeholders foresee added barriers stemming from utilization...
With the ever-increasing costs of drugs, experts are looking more closely at methods to contain costs for payers and improve affordability and access for patients; however, some stakeholders foresee added barriers stemming from utilization...
With the ever-increasing costs...
09/16/2021
First Report Managed Care
04/19/2019
As the federal government moves toward adopting and expanding value-based payment models, private market providers and payers are striving to smoothly transition to the new models, furthering the transformation of thought and practice of how...
As the federal government moves toward adopting and expanding value-based payment models, private market providers and payers are striving to smoothly transition to the new models, furthering the transformation of thought and practice of how...
As the federal government moves...
04/19/2019
First Report Managed Care
07/14/2015
The anticipated arrival of the first biosimilar in the United States came on March 6, 2015, with the FDA’s approval of ZarxioTM (filgras- tim-sndz).
The anticipated arrival of the first biosimilar in the United States came on March 6, 2015, with the FDA’s approval of ZarxioTM (filgras- tim-sndz).
The anticipated arrival of the...
07/14/2015
First Report Managed Care
04/22/2013
Results of a study show that individual measures of quality provide only a modest association with overall quality of neonatal intensive care units (NICUs).
Results of a study show that individual measures of quality provide only a modest association with overall quality of neonatal intensive care units (NICUs).
Results of a study show that...
04/22/2013
First Report Managed Care
02/22/2012
Chicago—New recommendations for the treatment of rheumatoid arthritis (RA) are near completion and will provide evidence-based recommendations on a number of issues related to the use of biologics and traditional disease-modifying...
Chicago—New recommendations for the treatment of rheumatoid arthritis (RA) are near completion and will provide evidence-based recommendations on a number of issues related to the use of biologics and traditional disease-modifying...
Chicago—New recommendations for...
02/22/2012
First Report Managed Care